Results 71 to 80 of about 1,124 (174)
Debashis Biswas,1 Beverly Karabin,2 Debra Turner3 1Neurology, Baptist Memorial Hospital-Memphis, Memphis, TN, USA; 2Cardiovascular Medicine, University of Toledo, Toledo, OH, USA; 3Autonomic Services, Semmes Murphey Clinic, Memphis, TN, USA Abstract ...
Biswas D, Karabin B, Turner D
doaj
Neurogenic orthostatic hypotension (nOH) causes disabling symptoms such as dizziness, impaired daily activities, and increased fall risk. Droxidopa is approved for symptomatic treatment, but individual trials have reported heterogeneous results across ...
Fornari Caprara, Ana Leticia, MD +5 more
core
The Treatment of Primary Orthostatic Hypotension
OBJECTIVE: To review the efficacy and safety of pharmacological and nonpharmacological strategies used to treat primary orthostatic hypotension (OH).
Valdes, Jose +2 more
core +1 more source
idrolisi enantioselettiva di droxidopa e suoi analoghi catalizzata da penicillina G acilasi ...
TERRENI, MARCO +2 more
core
Safety and efficacy of droxidopa for dysautonomia in adults with Menkes disease and occipital horn syndrome in the USA: a randomised phase 1/2a crossover trial. [PDF]
Kaler MM +10 more
europepmc +1 more source
887: DROXIDOPA FOR THE MANAGEMENT OF HEPATORENAL SYNDROME
Brian Murray +4 more
openaire +2 more sources
Symptoms are an optimal target for orthostatic hypotension screening and management: an argument in favor. [PDF]
Lopez Castellanos JR.
europepmc +1 more source
Pharmacological Interventions for Orthostatic Hypotension: A Systematic Review. [PDF]
Verma A +6 more
europepmc +1 more source
Radiation-Induced Baroreflex Dysfunction: A Rare Case of Severe Orthostatic Hypotension. [PDF]
So PN +4 more
europepmc +1 more source
The 14th International Congress of Parkinson's Disease and Movement Disorders, held in Buenos Aires, included topics covering new therapeutic developments in the field of Parkinson's disease and other movement disorders. This conference report highlights
Grosset, D., Grosset, A.
core

